Global Bio-chem Technology Group Company Limited
Global Bio-chem Technology Group Company Limited (GBCMY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
gbcmy · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Global Bio-chem Technology Group Company Limited (GBCMY) measures how much investors pay for each dollar of the company's trailing earnings. GBCMY's current PE ratio of 17.35x is calculated by dividing its stock price of $0.41 by its TTM earnings per share of $0.00. +1011.9% elevated vs 5Y avg 1.6x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 8 fiscal years · Front-end computedMinQ1 · 25%0.6x
MedianQ3 · 75%5.3x
Max
At 17.35x, GBCMY's current P/E is higher than in 100% of its annual fiscal year readings over the past 8 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Packaged Foods · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Global Bio-chem Technology Group Company LimitedYou GBCMY | $74M | 17.35x | -0.8% | $0.00 |
 Bubs Australia Limited BUBSF | $69M | 22.03x | +25.9% | $0.01 |
 China Foods Limited CHFHY | $1.3B | 12.83x | -26.7% | $6.00 |
 Charlie's Holdings, Inc. CHUC | $62M | 17.62x | +0.7% | $0.02 |
 Comvita Limited CVNZF | $30M | N/A | — | -$1.49 |
 KP Tissue Inc. KPTSF | $95M | N/A | — | $0.00 |
 Naked Wines plc NWINF | $65M | N/A | — | -$0.07 |
Industry Average 3 peers with valid PE | — | 17.49x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 5.26x | $0.72 | +498.8% | |
2024-12-31 FY2024 | 0.88x | $4.31 | +177.9% | |
2023-12-31 FY2023 | 0.32x | $23.71 | — | |
2022-12-31 FY2022 | — | $-8.10 | — | |
2021-12-31 FY2021 | — | $-2.25 | — | |
2020-12-31 FY2020 | — | $-14.30 | — | |
2019-12-31 FY2019 | — | $-7.84 | — | |
2018-12-31 FY2018 | — | $-9.55 | — | |
2017-12-31 FY2017 | — | $-6.54 | — | |
2016-12-31 FY2016 | — | $-14.50 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Global Bio-chem Technology Group Company Limited (GBCMY) measures how much investors pay for each dollar of the company's trailing earnings. GBCMY's current PE ratio of 17.35x is calculated by dividing its stock price of $0.41 by its TTM earnings per share of $0.00.
Frequently asked questions
GBCMY pe ratio · 6 questionsGBCMY's current PE ratio is 17.35x as of 2026-06-09, based on a stock price of $0.41 and TTM EPS of $0.00. Data sourced from Financial Modeling Prep via GBCMY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Global Bio-chem Technology Group Company Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09